This Pill Can Halve The Risk of Death After Lung Cancer, Scientists Say

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

New drug combination offers ovarian cancer breakthrough

A randomized clinical trial found that higher-than-standard vitamin D3 supplementation in the first 2 years decreased risk of internalizing problems at ages 6 to 8 years.